# OnCo record paper-idea-duration-adjuvant-stage-iii-colon-nejm-2018 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-idea-duration-adjuvant-stage-iii-colon-nejm-2018/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-idea-duration-adjuvant-stage-iii-colon-nejm-2018" ;
  schema:name "Duration of adjuvant chemotherapy for stage III colon cancer (the IDEA collaboration)"@en ;
  schema:description "Six trials pooled 12,834 patients to ask whether three months of chemotherapy is as good as six. For lower-risk tumours treated with CAPOX it is, and the nerve damage is far less."@en ;
  schema:url <https://onco.cc/key-papers/paper-idea-duration-adjuvant-stage-iii-colon-nejm-2018/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://doi.org/10.1056/NEJMoa1713709>, <https://pubmed.ncbi.nlm.nih.gov/29590544/>, <https://europepmc.org/article/MED/29590544> ;
  onco:tag "colorectal-evidence" ;
  schema:sameAs <https://doi.org/10.1056/NEJMoa1713709> ;
  schema:datePublished "2018"^^xsd:gYear ;
  schema:author "Grothey A, Sobrero AF, Shields AF, et al." ;
  onco:related <https://onco.cc/key-papers/paper-mosaic-oxaliplatin-adjuvant-colon-nejm-2004/>, <https://onco.cc/key-papers/paper-esmo-localised-colon-cancer-guideline-ann-oncol-2020/> ;
  onco:cancers <https://onco.cc/cancers/colorectal/>, <https://onco.cc/cancers/colon-cancer/> ;
  onco:sections <https://onco.cc/fronts/chemotherapy/> ;
  onco:technologies <https://onco.cc/technologies/cytotoxic-chemotherapy/> ;
  onco:drugs <https://onco.cc/drugs/folfox/>, <https://onco.cc/drugs/capox/>, <https://onco.cc/drugs/oxaliplatin/>, <https://onco.cc/drugs/capecitabine/> ;
  onco:terms <https://onco.cc/terms/neoadjuvant-adjuvant/> ;
  onco:people <https://onco.cc/people/thierry-andre/>, <https://onco.cc/people/yoshino-takayuki/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-toxicity-qol/>, <https://onco.cc/bottlenecks/b-dose-optimisation/> ;
  onco:journals <https://onco.cc/journals/nejm/> .